Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

TherapeuticsMD Inc. (TXMD)

0.3135   -0.027 (-7.79%) 01-21 17:48
Open: 0.3359 Pre. Close: 0.34
High: 0.34 Low: 0.31
Volume: 4,054,389 Market Cap: 133M
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17Ã?-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.34 - 0.343 0.343 - 0.344
Low: 0.305 - 0.308 0.308 - 0.31
Close: 0.307 - 0.31 0.31 - 0.313

Technical analysis

as of: 2022-01-21 4:31:12 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.58     One year: 0.71
Support: Support1: 0.31    Support2: 0.26
Resistance: Resistance1: 0.50    Resistance2: 0.61
Pivot: 0.37
Moving Average: MA(5): 0.34     MA(20): 0.37
MA(100): 0.60     MA(250): 0.99
MACD: MACD(12,26): -0.03     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 7.13     %D(3): 7.37
RSI: RSI(14): 32.63
52-week: High: 2.75  Low: 0.31  Change(%): -80.3
Average Vol(K): 3-Month: 6272  10-Days: 3986

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TXMD has closed above bottom band by 7.5%. Bollinger Bands are 15.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 20 Jan 2022
$TXMD Technical Short Put Spread Fade the Dip Trade and Trigger - CML News

Wed, 05 Jan 2022
Thinking about buying stock in 9 Meters Biopharma, TherapeuticsMD, Cameco Corp, Nikola Corp, or Comstock Mining? - PRNewswire

Tue, 04 Jan 2022
34 Stocks Moving In Tuesday's Mid-Day Session - Benzinga - Benzinga

Tue, 04 Jan 2022
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge - Benzinga - Benzinga

Mon, 03 Jan 2022
TherapeuticsMD (TXMD) Receives Approval from FDA of sNDA for BIJUVA - StreetInsider.com

Thu, 30 Dec 2021
What Kind Of Investors Own Most Of TherapeuticsMD, Inc. (NASDAQ:TXMD)? - Simply Wall St

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 425
Shares Float (M) 395
% Held by Insiders 6.95
% Held by Institutions 36.96
Shares Short (K) 18,750
Shares Short P. Month (K) 33,180

Stock Financials

EPS -0.473
EPS Est This Year -0.440
EPS Est Next Year -0.330
Book Value (p.s.) -0.140
Profit Margin -188.82
Operating Margin -152.98
Return on Assets (ttm) -44.9
Return on Equity (ttm)
Qtrly Rev. Growth 31.4
Gross Profit (p.s.) 0.115
Sales Per Share 0.214
EBITDA (p.s.) -0.317
Qtrly Earnings Growth
Operating Cash Flow (M) -133
Levered Free Cash Flow (M) -71

Stock Valuations

PE Ratio -0.66
PEG Ratio
Price to Book value -2.24
Price to Sales 1.47
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.